{
    "Trade/Device Name(s)": [
        "Total Bilirubin Special"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K063744",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981632",
        "K063543",
        "K951595"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIG"
    ],
    "Summary Letter Date": "January 17, 2007",
    "Summary Letter Received Date": "December 18, 2006",
    "Submission Date": "December 15, 2006",
    "Regulation Number(s)": [
        "21CFR862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology",
        "misc"
    ],
    "Analyte(s)": [
        "Total bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Cup",
        "Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas c 111 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometry",
        "Diazo method"
    ],
    "Methodologies": [
        "Photometric analysis"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Total Bilirubin Special reagent and cobas c 111 analyzer for quantitative bilirubin determination in serum and plasma",
    "Indications for Use Summary": "In vitro test for the quantitative determination of total bilirubin in human serum and plasma on the cobas c 111 system, aiding in diagnosis of liver, hemolytic, hematological and metabolic disorders",
    "fda_folder": "Clinical Chemistry"
}